newsfilter
← Latest News
GlobeNewswire·

Longeveron Announces 1-for-10 Reverse Stock Split

MIAMI, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions,